| Sharing and Facilitating Discussions on the Latest Insights in the Field of Clinical Trials
JNPMEDI (CEO Kwunho Jeong) announced on the 31st that it will host Korea's largest digital clinical trial symposium, '2023 JNPMEDI Connect.'
Now in its second year, JNPMEDI Connect is an event designed for professionals leading the digital transformation in the field of clinical trials. The event provides a platform for various industry participants, including digital healthcare companies, pharmaceutical firms, clinical research organizations (CROs), university hospitals, and investors, to share expert knowledge and experiences.
As a leading DCT (Decentralized Clinical Trial) solution provider, JNP Medi has been driving growth in the domestic market and expanding its global influence. The company aims to foster collaboration by organizing this annual event.
The symposium will cover critical insights on global regulations and legal updates, the latest trends in digital solutions and their applications, as well as the challenges of building the next-generation clinical trial ecosystem. The event also promotes industry networking and knowledge sharing.
This year's event will be held on November 24, from 9 AM to 6 PM, at the Grand Ballroom of JW Marriott Hotel in Seoul.
JNPMEDI is expanding this year's symposium into a full-day event, with extended hours and a more diverse lineup of lectures, allowing for deeper academic discussions and more active networking, including business matching. The event is also expected to contribute to building collaborative networks within the industry.
CEO Kwunho Jeong stated, "As digital transformation accelerates in the healthcare sector, we hope this event, which brings together a broad range of perspectives on the present and future of clinical trials, will serve as a catalyst for new innovation and growth."
| Sharing and Facilitating Discussions on the Latest Insights in the Field of Clinical Trials
JNPMEDI (CEO Kwunho Jeong) announced on the 31st that it will host Korea's largest digital clinical trial symposium, '2023 JNPMEDI Connect.'
Now in its second year, JNPMEDI Connect is an event designed for professionals leading the digital transformation in the field of clinical trials. The event provides a platform for various industry participants, including digital healthcare companies, pharmaceutical firms, clinical research organizations (CROs), university hospitals, and investors, to share expert knowledge and experiences.
As a leading DCT (Decentralized Clinical Trial) solution provider, JNP Medi has been driving growth in the domestic market and expanding its global influence. The company aims to foster collaboration by organizing this annual event.
The symposium will cover critical insights on global regulations and legal updates, the latest trends in digital solutions and their applications, as well as the challenges of building the next-generation clinical trial ecosystem. The event also promotes industry networking and knowledge sharing.
This year's event will be held on November 24, from 9 AM to 6 PM, at the Grand Ballroom of JW Marriott Hotel in Seoul.
JNPMEDI is expanding this year's symposium into a full-day event, with extended hours and a more diverse lineup of lectures, allowing for deeper academic discussions and more active networking, including business matching. The event is also expected to contribute to building collaborative networks within the industry.
CEO Kwunho Jeong stated, "As digital transformation accelerates in the healthcare sector, we hope this event, which brings together a broad range of perspectives on the present and future of clinical trials, will serve as a catalyst for new innovation and growth."